Sabby Management’s Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 PHIOW Stock Holding History

Sabby Management’s Portfolio PHIOW Stock Details PHIOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-194,959	Closed	-$5K	–	117
2019 Q1	$5K	Hold	194,959	–	–	﹤0.01%	77
2018 Q4	$5K	Buy	+194,959	New	+$7.78K	﹤0.01%	119

Other funds holding PHIOW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Sabby Management's PHIOW Position: Q2 2019 in Review

Sabby Management sold out of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) in Q2 2019, closing a stake of 194,959 shares — an estimated $5K sold.

Sabby Management first reported a position in PHIOW in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 4 funds tracked by Wall St. Rank hold PHIOW as of Q2 2019.

Sabby Management reported no remaining Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 position as of Q2 2019 after selling out during the quarter.
Sabby Management sold 194,959 Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 shares in Q2 2019, an estimated $5K.
Sabby Management first reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in Q4 2018 and held it in 2 quarters.
Sabby Management's Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 position peaked at $5K in Q1 2019.
4 funds tracked by Wall St. Rank held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 as of Q2 2019.

Based on Sabby Management's 13F filing for Q2 2019, filed 14 Aug 2019.